Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Stefanie Gilchrist"'
Autor:
Ray Borrow, Lynne S. Newbold, Julia S. Bennett, Jamie Findlow, Martin C. J. Maiden, Jay Lucidarme, Lynne Richardson, Stefanie Gilchrist, Edward B. Kaczmarski, Stephen J. Gray
Publikováno v:
Clinical and Vaccine Immunology. 20:1360-1369
The poor immunogenicity of the meningococcal serogroup B (MenB) capsule has led to the development of vaccines targeting subcapsular antigens, in particular the immunodominant and diverse outer membrane porin, PorA. These vaccines are largely strain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c44608a8e4e55de6ca8d6b12c2c38845
https://doi.org/10.1128/cvi.00090-13
https://doi.org/10.1128/cvi.00090-13
Autor:
Pietro Giorgio Lovaglio, Morgan Ledroit, Anna Carannante, Fabio Rigat, Maurizio Comanducci, Cecilia Fazio, Raquel Abad, Giacomo Frosi, Jamie Findlow, Dominique A. Caugant, Ulrich Vogel, Muhamed-Kheir Taha, John J. Donnelly, Duccio Medini, Jay Lucidarme, Danielle Thompson, Davide Serruto, Martin Musilek, Maria Stella, Stefanie Gilchrist, Alessandro Muzzi, Paola Stefanelli, Ala Eddine Deghmane, Luca Orlandi, Eva Hong, Stefania Bambini, Ray Borrow, Heike Claus, Giuseppe Boccadifuoco, Julio A. Vázquez, Marzia Monica Giuliani, Paula Kriz, Rino Rappuoli, Jan Oksnes, Matthias Frosch, Mariagrazia Pizza
Publikováno v:
The Lancet Infectious Diseases
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2013, 13 (5), pp.416-425. ⟨10.1016/S1473-3099(13)70006-9⟩
The Lancet Infectious Diseases, 2013, 13 (5), pp.416-425. ⟨10.1016/S1473-3099(13)70006-9⟩
The Lancet Infectious Diseases, New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001-, 2013, 13 (5), pp.416-425. ⟨10.1016/S1473-3099(13)70006-9⟩
The Lancet Infectious Diseases, 2013, 13 (5), pp.416-425. ⟨10.1016/S1473-3099(13)70006-9⟩
Summary Background A novel multicomponent vaccine against meningococcal capsular group B (MenB) disease contains four major components: factor-H-binding protein, neisserial heparin binding antigen, neisserial adhesin A, and outer-membrane vesicles de
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::faa0bc516ab8b5debdcd20e8d139ff49
https://doi.org/10.1016/s1473-3099(13)70006-9
https://doi.org/10.1016/s1473-3099(13)70006-9
Autor:
Ifeanyichukwu O Okike, Adam Finn, Rohit Bazaz, John Williams, Kamlesh Patel, Paul T. Heath, Steve J. Gray, David J. M. Lewis, Maggie McCarthy, Matthew D. Snape, Begonia Morales-Aza, Andrew J. Pollard, Robert C. Read, Huajun Wang, David Baxter, Stefanie Gilchrist, Saul N. Faust, Keith R. Neal, Daniela Toneatto, Tom Havelock, David P. J. Turner, Martin C. J. Maiden, David Chadwick, Amitava Ganguli, Stephen B. Gordon, Ray Borrow, Peter M. Dull
Publikováno v:
Lancet (London, England). 384(9960)
Summary Background Meningococcal conjugate vaccines protect individuals directly, but can also confer herd protection by interrupting carriage transmission. We assessed the effects of meningococcal quadrivalent glycoconjugate (MenACWY-CRM) or serogro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d1453498b0b4dc63ef14b09867279d8f
https://pubmed.ncbi.nlm.nih.gov/25797556
https://pubmed.ncbi.nlm.nih.gov/25797556
Autor:
Stefanie Gilchrist, Morena Lo Sapio, Jay Lucidarme, Giacomo Frosi, Ray Borrow, Mariagrazia Pizza, Duccio Medini, Jamie Findlow, Marzia Monica Giuliani, Alessia Biolchi, Fabio Rigat
Publikováno v:
Vaccine. 31(43)
Background 4CMenB (Bexsero), a vaccine developed against invasive meningococcal disease caused by capsular group B strains (MenB), was recently licensed for use by the European Medicines Agency. Assessment of 4CMenB strain coverage in specific epidem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce471d04a0029a71bb4056798a5e0211
https://pubmed.ncbi.nlm.nih.gov/32624253
https://pubmed.ncbi.nlm.nih.gov/32624253
Autor:
Muhamed-Kheir Taha, Duccio Medini, Brunella Brunelli, Dominique A. Caugant, Jan Oksnes, Elisabeth Fritzsønn, Gowrisankar Rajam, John J. Donnelly, Ulrich Vogel, Brian D. Plikaytis, Rino Rappuoli, Laura Santini, Anne-Marie Klem, George M. Carlone, Mauro Agnusdei, Anna Carannante, Julio A. Vázquez, Stefanie Gilchrist, Eva Hong, Paola Stefanelli, Isabella Simmini, Maria Stella, Marzia Monica Giuliani, Giuseppe Boccadifuoco, Cecilia Fazio, Luca Orlandi, Ray Borrow, Lisa DeTora, Heike Claus, Mariagrazia Pizza, Raquel Abad, Kim Ellie, Jamie Findlow, Morgan Ledroit
Publikováno v:
Clinical and Vaccine Immunology
Clinical and Vaccine Immunology, 2012, 19 (10), pp.1609-1617. ⟨10.1128/CVI.00202-12⟩
Clinical and Vaccine Immunology, American Society for Microbiology, 2012, 19 (10), pp.1609-1617. ⟨10.1128/CVI.00202-12⟩
Clinical and Vaccine Immunology, 2012, 19 (10), pp.1609-1617. ⟨10.1128/CVI.00202-12⟩
Clinical and Vaccine Immunology, American Society for Microbiology, 2012, 19 (10), pp.1609-1617. ⟨10.1128/CVI.00202-12⟩
The meningococcal antigen typing system (MATS) sandwich enzyme-linked immunosorbent assay (ELISA) was designed to measure the immunologic cross-reactivity and quantity of antigens in target strains of a pathogen. It was first used to measure the fact
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6d823d81ec4810a8de48c99a74ecfb94
https://hal-pasteur.archives-ouvertes.fr/pasteur-02085510
https://hal-pasteur.archives-ouvertes.fr/pasteur-02085510
Autor:
Jay Lucidarme, Lynne S. Newbold, Anthony D. Carr, Jamie Findlow, James Hewitt, Stefanie Gilchrist, Ray Borrow, Edward B. Kaczmarski, Stephen J. Gray
In 2007, recommendations were proposed for the molecular typing of meningococci. Multilocus sequence typing (MLST) was recommended to guide national and international disease management and facilitate studies of population biology and evolution. Sequ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb33b9a51e5b42eae4d06cab7ee3114a
https://europepmc.org/articles/PMC3067353/
https://europepmc.org/articles/PMC3067353/